OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di

actpapercliniciantier 1link inconclusivelink-only

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This randomized controlled trial compares the efficacy of Acceptance and Commitment Therapy combined with SSRIs against Exposure and Response Prevention plus SSRIs, as well as continued SSRI treatment alone, for patients with Obsessive-Compulsive Disorder. The study includes 40 participants and was conducted in Iran. It is a preliminary examination published in Behavior Modification.

ID
a25c8ce43ca74619
Source org
ACBS
Author
Mehdi Zemestani (University of Kurdistan), Mojgan Salavati (University of Kurdistan), Asrin Seyedolshohadayi (Kurdistan University of Medical Sciences), Julie M. Petersen (Utah State University), Clarissa W. Ong (Utah State University), Michael P. Twohig (Utah State University), Ebrahim Ghaderi (Kurdistan University of Medical Sciences)
Published
2020-12-24
OA status
closed
DOI
10.1177/0145445520982977
PMID
Not recorded
PMCID
Not recorded
Citations
23

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:a25c8ce43ca74619,
  title = {OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di},
  author = {Mehdi Zemestani and Mojgan Salavati and Asrin Seyedolshohadayi and Julie M. Petersen and Clarissa W. Ong and Michael P. Twohig and Ebrahim Ghaderi},
  year = {2020},
  journal = {ACBS},
  doi = {10.1177/0145445520982977},
  url = {https://doi.org/10.1177/0145445520982977}
}

RIS

TY  - JOUR
TI  - OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di
AU  - Zemestani, Mehdi
AU  - Salavati, Mojgan
AU  - Seyedolshohadayi, Asrin
AU  - Petersen, Julie M.
AU  - Ong, Clarissa W.
AU  - Twohig, Michael P.
AU  - Ghaderi, Ebrahim
PY  - 2020
PB  - ACBS
DO  - 10.1177/0145445520982977
UR  - https://doi.org/10.1177/0145445520982977
ER  -

APA

Zemestani, M., Salavati, M., Seyedolshohadayi, A., Petersen, J. M., Ong, C. W., Twohig, M. P., & Ghaderi, E. (2020). OCD symptoms. ACT+SSRIs, vs. Exposure and response prevention +SSRI, vs. continued SSRIs. N=40. Zemestani M, Salavati M, Seyedolshohadayi A, et al. (2022). A Preliminary Examination of Acceptance and Commitment Therapy Versus Exposure and Response Prevention for Patients with Obsessive-Compulsive Di. ACBS. https://doi.org/10.1177/0145445520982977

Related entries

More like this